AZIZ SHAIBANI to Treatment Outcome
This is a "connection" page, showing publications AZIZ SHAIBANI has written about Treatment Outcome.
Connection Strength
0.118
-
Placebo response in pain, fatigue, and performance: Possible implications for neuromuscular disorders. Muscle Nerve. 2017 09; 56(3):358-367.
Score: 0.033
-
Swallowing-induced Supraventricular Tachyarrhythmia. Rev Cardiovasc Med. 2017; 18(1):53-58.
Score: 0.032
-
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. Neurology. 2021 03 23; 96(12):e1595-e1607.
Score: 0.011
-
Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clin Transl Sci. 2021 05; 14(3):1176-1184.
Score: 0.010
-
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol. 2019 09; 18(9):834-844.
Score: 0.010
-
Randomized Trial of Thymectomy in Myasthenia Gravis. N Engl J Med. 2016 08 11; 375(6):511-22.
Score: 0.008
-
Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy. J Peripher Nerv Syst. 2015 Dec; 20(4):363-71.
Score: 0.007
-
Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain. 2007 Feb; 23(2):150-8.
Score: 0.004
-
Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand. 2006 Jun; 113(6):395-404.
Score: 0.004